Alzheimer Market: Drugs, Therapeutics & Diagnostics Research Reports RnR Market Research adds new market research reports on Alzheimer's disease treatment covering drugs, therapeutic and diagnostic technologies.

DALLAS, May 29, 2013 /PRNewswire-iReach/ -- Global Alzheimer's Drugs Market 2012-2016, Alzheimer's Disease Therapeutics and Diagnostics: Global Markets and Alzheimer Disease Treatment Drugs Markets in China are new market research reports available with RnRMarketResearch.com.

(Photo: http://photos.prnewswire.com/prnh/20130529/CG21228)

Global Alzheimer's Drugs market is forecast to grow at a CAGR of 3.26% over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Alzheimer's Drugs market has also been witnessing the availability of improved diagnostics. However, numerous patent expiries could pose a challenge to the growth of this market. Alzheimer's disease is becoming an increasingly difficult challenge to caregivers, families and the healthcare industry as the number of patients climb and the frustration with lack of effective treatments grows. Though there are a number of marketed drugs approved for AD, this remains a significant area of unmet medical need. Clinical success has proven elusive; however, there are now numerous companies developing novel treatments.

The report Global Alzheimer's Drugs Market 2012-2016 covers the worldwide Alzheimer's drugs market in the Americas, the EMEA, and the APAC regions, its market landscape, and growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market including but not limited to Eisai Co., Ltd., Forest Laboratories Inc., H. Lundbeck A/S., Novartis AG, and Pfizer Inc. Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98045.

The scope of the report Alzheimer's Disease Therapeutics and Diagnostics: Global Markets is on the pharmaceutical segment, diagnostics and imaging modalities. It is a compiled study of the market, and current and emerging modes of treatment. The research presents the market segment's economic environment, technological descriptions and issues, applications, market factors and potential, and forecasts for 2012 to 2017. It also projects usage in the major primary and secondary disease application areas. This study will be of interest to the drug industry, patients, and the medical community. It will be of interest also to suppliers of products and services to this market area. The intended audience for this report is the pharmaceutical and biotechnology industries and diagnostics, as well as the medical industry that treats patients in these areas. Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=96663.

China's demand for alzheimer disease treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. The new research Alzheimer Disease Treatment Drugs Markets in China examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in China are profiled. Production, demand, sales volume and more for the following have been covered in this report: Ginkgo Bilota Extract, Breviscapine, Ganglioside, Donepezil, Galanthamine, Nicergoline, Rivastigmine, Memantine, Huperzine A,  Oxiracetam, Flunarizine and Piracetam. Buy / Order a copy of this report at 50% discount http://www.rnrmarketresearch.com/contacts/purchase?rname=90552 – listed price is $4000 for a single user license – the same can be availed for US$2000; kindly contact sales@rnrmarketresearch.com with your request for this discounted pricing.

Explore more reports on Alzheimer Drugs and related markets @ http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/diseases-treatment/alzheimer-drugs.

About Us:

RnRMarketResearch.com (http://www.rnrmarketresearch.com/) is an online market research reports library of 250,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.

Explore multi-industry reports targeted at geographies across the globe @ http://marketreportsstore.com/. We also have business intelligence and competitive analysis studies focused on multiple industries in China available @ http://www.marketreportschina.com/.

Media Contact:

Priyank Tiwari RnR Market Research, +1 888 391 5441, sales@rnrmarketresearch.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE RnR Market Research



RELATED LINKS
http://www.rnrmarketresearch.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.